Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0f4f8190960626ec922a1f03bcd4aba |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 |
filingDate |
2011-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9ec7f88f449ed384bc2867a99611872 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc46da960370453bf9f78c2a24ee87ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf5e5c84b23ec4b870c169703806b53a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d7d2d185ee807b6f9f33bceea1762e8 |
publicationDate |
2011-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2792036-A1 |
titleOfInvention |
Polymorph of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid |
abstract |
The present invention provides crystalline Form R of 2-[3-cyano-4-(2- methylpropoxy) phenyl]-4-methylthiazole-5-carboxylic acid, process for its preparation, pharmaceutical composition comprising it and its use for the chronic management of hyperuricemia in patients with gout. |
priorityDate |
2010-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |